COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/VALSARTAN IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ELIGIBLE PATIENTS

被引：0
|
作者：
Kaddoura, R. [1 ]
Abushanab, D. [2 ]
Arabi, A. R. [3 ]
Al-Badriyeh, D. [4 ]
机构：
[1] Hamad Med Corp, Heart Hosp, Pharm Dept, Doha, Qatar
[2] Hamad Med Corp, Doha, Qatar
[3] Hamad Med Corp, Heart Hosp, Cardiol Dept, Doha, Qatar
[4] Qatar Univ, Qatar Univ Hlth, Coll Pharm, Doha, Qatar
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE432
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [21] The reality of implantable cardioverter-defibrillator longevity: What can be done to improve cost-effectiveness?
    Russo, Andrea M.
    HEART RHYTHM, 2012, 9 (04) : 520 - 521
  • [22] STRATEGIES TO IMPROVE COST-EFFECTIVENESS OF THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    GUERERRO, P
    HOGAN, A
    GARDINER, J
    MELLITS, D
    BAUMGARDNER, R
    LEVINE, J
    ROVNER, D
    HOLMESROVNER, M
    GRIFFITH, L
    KUPERSMITH, J
    CLINICAL RESEARCH, 1993, 41 (02): : A122 - A122
  • [23] Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review
    Teimourizad, Abedin
    Rezapour, Aziz
    Sadeghian, Saeed
    Tajdini, Masih
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2021, 19 (01)
  • [24] The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator
    Yao, Guiqing
    Freemantle, Nick
    Calvert, Melanie J.
    Bryan, Stirling
    Daubert, Jean-Claude
    Cleland, John G. F.
    EUROPEAN HEART JOURNAL, 2007, 28 (01) : 42 - 51
  • [25] COST-EFFECTIVENESS OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFECT OF IMPROVED BATTERY LIFE AND COMPARISON WITH AMIODARONE THERAPY
    LARSEN, GC
    MANOLIS, AS
    SONNENBERG, FA
    BESHANSKY, JR
    ESTES, NAM
    PAUKER, SG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) : 1323 - 1334
  • [26] Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure
    Woo, Christopher Y.
    Strandberg, Erika J.
    Schmiegelow, Michelle D.
    Pitt, Allison L.
    Hlatky, Mark A.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (06) : 417 - +
  • [27] Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review
    Abedin Teimourizad
    Aziz Rezapour
    Saeed Sadeghian
    Masih Tajdini
    Cost Effectiveness and Resource Allocation, 19
  • [28] Tumescent local anesthesia versus general anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: A cost-effectiveness analysis
    Romero, Jorge
    Rodriguez-Taveras, Joan
    Diaz, Juan Carlos
    Lorente-Ros, Marta
    Braunstein, Eric D.
    Alviz, Isabella
    Parides, Michael
    Haroun, Magued W.
    Papa, Lauren
    Dave, Kartikeya
    Rodriguez, Daniel
    Krishnan, Suraj
    Toquica, Christian
    Velasco, Alejandro
    Gabr, Mohamed
    Natale, Andrea
    Di Biase, Luigi
    HEART RHYTHM, 2023, 20 (04) : 522 - 529
  • [29] ORIGINAL RESEARCH Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan
    Begisbayev, Temirkhan
    Kosherbayeva, Lyazzat
    Gaitova, Kamilla
    Brimzhanova, Marzhan
    VASCULAR HEALTH AND RISK MANAGEMENT, 2022, 18 : 813 - 821
  • [30] Is the implantable cardioverter-defibrillator cost-effective?
    Levy, S
    EUROPEAN HEART JOURNAL, 1996, 17 (10) : 1458 - 1459
12345